American Association for Cancer Research

AACR 101st Annual Meeting 2010: Forums

As of March 3, 2010

Monday, April 19
5:00 p.m.-6:30 p.m.

Advancing Cancer Biomarkers to Cancer Diagnostics: Increasing the Pace of Progress

Moderator: Anna D. Barker, National Cancer Institute, Bethesda, MD

    Speakers:
  • Joe W. Gray, Lawrence Berkeley National Laboratory, Berkeley, CA
  • Sanjiv Sam Gambhir, Stanford University, Stanford, CA
  • Laura Esserman, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

Animal Models for Preclinical Evaluation of Drugs for Metastatic Disease: Are GEMs the Jewel in the Crown or an Expensive Luxury?

Moderator: Suzanne A. Eccles, McElwain Laboratories, Sutton, United Kingdom

    Speakers:
  • Terry A. Van Dyke, NCI-Frederick, Frederick, MD
  • Ann Richmond, Vanderbilt-Ingram Cancer Center, Nashville, TN

Antiangiogenic Therapy-Induced Malignant Progression: Preclinical Anomaly or Clinical Reality

Moderator: Robert S. Kerbel, University of Toronto Sunnybrook Health Sciences Centre, Toronto, ON, Canada

    Speakers:
  • Gregory D. Plowman, Genentech, Inc., South San Francisco, CA
  • Donald M. McDonald, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

Antioxidants and Cancer Prevention: Molecular, Epidemiologic, and Public Perspectives

Moderator: Eric A. Klein, The Cleveland Clinic Lerner Research Institute, Cleveland, OH

    Speakers:
  • Alan R. Kristal, Fred Hutchinson Cancer Research Center, Seattle, WA
  • Regina M. Santella, Columbia University Mailman School of Public Health, New York, NY
  • Tara Parker-Pope, New York Times, New York, NY

Circulating Tumor Cells: Finding Them and Understanding Them

Moderator: Daniel A. Haber, Massachusetts General Hospital, Charlestown, MA

    Speakers:
  • Klaus Pantel, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  • Gerhardt Attard, Institute of Cancer Research, Sutton, United Kingdom

 

Tuesday, April 20
5:00 p.m.-6:30 p.m.

Anti-TGFβ Signaling Therapy: Balancing the Pros and Cons

Moderator: Rosemary J. Akhurst, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

    Speakers:
  • Steven M. Albelda, Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA
  • Neil A. Bhowmick, Vanderbilt University, Nashville, TN

Cancer Stem Cells: Somewhere, Everywhere, or Nowhere?

Moderator: Emmanuelle Passegué, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

    Speakers:
  • Tessa L. Holyoake, University of Glasgow, Glasgow, United Kingdom
  • Jeffrey M. Rosen, Baylor College of Medicine, Houston, TX

Cellular Senescence: Molecular Basis and Relevance for Cancer

Moderator: Jiri Bartek, Danish Cancer Society, Copenhagen, Denmark

    Speakers:
  • Fabrizio d’Adda di Fagagna, IFOM Foundation, Milano, Italy
  • Pier Paolo Pandolfi, Beth Israel Deaconess Medical Center, Boston, MA

Oncology Drug Discovery in Academia: Key Strategies and Challenges

Moderator: Michael Morrissey, Exelixis, South San Francisco, CA

    Speakers:
  • James H. Doroshow, National Cancer Institute, Bethesda, MD
  • Neil W. Gibson, Pfizer, Inc., La Jolla, CA

Integrating Immunology with Cancer Biology and Medicine

Moderator: Glenn Dranoff, Dana-Farber Cancer Institute, Boston, MA

    Speakers:
  • Wolf Hervé Fridman, Unité INSERM 255, Paris, France
  • Jedd D. Wolchok, Memorial Sloan-Kettering Cancer Center, New York, NY

The Role of Vitamin D in Cancer Prevention: What Do We Really Know?

Moderator: Virginia W. Hartmuller, The Scientific Consulting Group, Inc., Gaithersburg, MD

    Speakers:
  • Rachael Z. Stolzenberg-Solomon, National Cancer Institute, Rockville, MD
  • Edward L. Giovannucci, Harvard School of Public Health, Boston, MA
  • Joanne E. Manson, Brigham and Women’s Hospital, Boston, MA